Publication | Closed Access
A phase 1b study of placenta‐derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis
282
Citations
20
References
2014
Year
Intravenous MSC administration is feasible and has a good short-term safety profile in patients with moderately severe IPF.
| Year | Citations | |
|---|---|---|
Page 1
Page 1